A systematic review and meta-analysis of clinical trials investigating the effects of flaxseed supplementation on plasma C-reactive protein concentrations

Authors:

Sorin Ursoniu | Amirhossein Sahebkar | Maria-Corina Serban | Iulia Pinzaru | Cristina Dehelean | Lavinia Noveanu | Jacek Rysz | Maciej Banach | Lipid and Blood Pressure Meta-Analysis Collaboration (LBPMC) Group
First published: …………… |https://doi.org/10.5114/aoms.2018.81034

Abstract:

Introduction:
Many experimental and clinical trials have suggested that flaxseed might be a potent antihypertensive, but the evidence concerning the effects of flaxseed supplements on plasma C-reactive protein (CRP) concentrations has not been fully conclusive. We assessed the impact of the effects of flaxseed supplementation on plasma CRP concentrations through a systematic review of literature and meta-analysis of available randomised controlled trials (RCTs).

Material and methods:
The literature search included EMBASE, ProQuest, CINAHL, and PUBMED databases up to 1st February 2016 to identify RCTs investigating the effect of flaxseed supplements on plasma CRP concentrations. Meta-analysis was performed using a random-effects model, and effect size was expressed as weighed mean difference (WMD) and 95% confidence interval (CI).

Results:
Meta-analysis of 17 selected RCTs with 1256 individuals did not suggest a significant change in plasma CRP concentrations following supplementation with flaxseed-containing products (WMD: –0.25 mg/l, 95% CI: –0.53, 0.02, p = 0.074). The effect size was robust in the leave-one-out sensitivity analysis. Subgroup analysis did not suggest any significant difference in terms of changing plasma CRP concentrations among different types of flaxseed supplements used in the included studies, i.e. flaxseed oil (WMD: –0.67 mg/l, 95% CI: –2.00, 0.65, p = 0.320), lignan extract (WMD: –0.32 mg/l, 95% CI: –0.71, 0.06, p = 0.103) and ground powder (WMD: –0.18 mg/l, 95% CI: –0.42, 0.06, p = 0.142).

Conclusions:
The meta-analysis of RCTs did not show a significant change in plasma CRP concentrations following supplementation with various flaxseed products. Large, well-designed studies should be still performed to validate the current results.

Full content publication available for download

Download
  1. Goyal A, Sharma V, Upadhyay N, Gill S, Sihag M. (2014). Flax and flaxseed oil: an ancient medicine and modern functional food J Food Sci Technol. 51: 1633-53.
  2. Shim YY, Gui B, Arnison PG, Wang Y, Reaney MJT. (2014). Flaxseed (Linum usitatissimum L.) bioactive compounds and peptide nomenclature: a review Trends Food Sci Technol. 38: 5-20.
  3. Zuravski L, Coelho RP, Duarte JA, et al. (2015). Protective role of golden flaxseed (Linum usitatissimum L.) against oxidative damage in lipids and proteins of healthy volunteers J Biosci Med. 3: 45-53.
  4. Edel AL, Rodriguez-Leyva D, Maddaford TG, et al. (2015). Dietary flaxseed independently lowers circulating cholesterol and lowers it beyond the effects of cholesterol-lowering medications alone in patients with peripheral artery disease J Nutrition. 145: 749-57.
  5. Caligiuri SP, Edel AL, Aliani M, Pierce GN. (2014). Flaxseed for hypertension: implications for blood pressure regulation Curr Hypertens Rep. 16: 499.
  6. Khalatbari Soltani, Jamaluddin R, Tabibi H, et al. (2013). Effects of flaxseed consumption on systemic inflammation and serum lipid profile in hemodialysis patients with lipid abnormalities Hemodial Int. 17: 275-81.
  7. Kajla P, Sharma A, Sood DR. (2015). Flaxseed – a potential functional food source J Food Sci Technol. 52: 1857-71.
  8. Sahebkar A, Serban C, Ursoniu S, Banach M. (2016). Effect of garlic on plasma lipoprotein(a) concentrations: a systematic review and meta-analysis of randomized controlled clinical trials Nutrition. 32: 33-40.
  9. Serban C, Sahebkar A, Antal D, Ursoniu S, Banach M. (2015). Effects of supplementation with green tea catechins on plasma C-reactive protein concentrations: a systematic review and meta-analysis of randomized controlled trials Nutrition. 31: 1061-71.
  10. Serban MC, Sahebkar A, Dragan S, et al. (2016). A systematic review and meta-analysis of the impact of spirulina supplementation on plasma lipid concentrations Clin Nutr. 35: 842-51.
  11. Prasad K. (2006). C-reactive protein (CRP)-lowering agents Cardiovasc Drug Rev. 24: 33-50.
  12. Koenig W, Sund M, Fröhlich M, et al. (1999). C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992 Circulation. 99: 237-42.
  13. Ridker PM, Hennekens CH, Buring JE, Rifai N. (2000). C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med. 342: 836-43.
  14. Rhee Y, Brunt A. (2011). Flaxseed supplementation improved insulin resistance in obese glucose intolerant people: a randomized crossover design Nutr J. 10: 44..
  15. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ. 339: b2535..
  16. Green S. (2011). Cochrane handbook for systematic reviews of interventions version 5.1. 0 [updated March 2011].
  17. Borenstein M, et al. (2005). Comprehensive meta-analysis version 2. 104. Biostat, Englewood, NJ.
  18. Wan X, Wang W, Liu J, Tong T. (2014). Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range BMC Med Res Methodol. 14: 135..
  19. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F. (2000). Methods for meta-analysis in medical research. John Wiley, New York.
  20. Duval S, Tweedie R. (2000). Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis Biometrics. 56: 455-63.
  21. Kontogianni MD, Vlassopoulos A, Gatzieva A, et al. (2013). Flaxseed oil does not affect inflammatory markers and lipid profile compared to olive oil, in young, healthy, normal weight adults Metabolism. 62: 686-93.
  22. Hutchins AM, Brown BD, Cunnane SC, Domitrovich SG, Adams ER, Bobowiec CE. (2013). Daily flaxseed consumption improves glycemic control in obese men and women with pre-diabetes: a randomized study Nutr Res. 33: 367-75.
  23. Zong G, Demark-Wahnefried W, Wu H, Lin X. (2013). Effects of flaxseed supplementation on erythrocyte fatty acids and multiple cardiometabolic biomarkers among Chinese with risk factors of metabolic syndrome Eur J Nutr. 52: 1547-51.
  24. Barre DE, Mizier-Barre KA, Stelmach E, et al. (2012). Flaxseed lignan complex administration in older human type 2 diabetics manages central obesity and prothrombosis – an invitation to further investigation into polypharmacy reduction J Nutr Metabol. 2012: 585170..
  25. Lemos JR, Alencastro MG, Konrath AV, Cargnin M, Manfro RC. (2012). Flaxseed oil supplementation decreases C-reactive protein levels in chronic hemodialysis patients Nutr Res. 32: 921-7.
  26. Rhee Y, Brunt A. (2011). Flaxseed supplementation improved insulin resistance in obese glucose intolerant people: a randomized crossover design Nutr J. 10: 44..
  27. Faintuch J, Bortolotto LA, Marques PC, Faintuch JJ, França JI, Cecconello I. (2011). Systemic inflammation and carotid diameter in obese patients: pilot comparative study with flaxseed powder and cassava powder Nutr Hosp. 26: 208-13.
  28. Pan A, Demark-Wahnefried W, Ye X, et al. (2009). Effects of a flaxseed-derived lignan supplement on C-reactive protein, IL-6 and retinol-binding protein 4 in type 2 diabetic patients Br J Nutr. 101: 1145-9.
  29. Dodin S, Cunnane SC, Mâsse B, et al. (2008). Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial Nutrition. 24: 23-30.
  30. Bloedon LT, Balikai S, Chittams J, et al. (2008). Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial J Am Coll Nutr. 27: 65-74.
  31. Hallund J, Tetens I, Bügel S, Tholstrup T, Bruun JM. (2008). The effect of a lignan complex isolated from flaxseed on inflammation markers in healthy postmenopausal women Nutr Metab Cardiovasc Dis. 18: 497-502.
  32. Kaul N, Kreml R, Austria JA, et al. (2008). A comparison of fish oil, flaxseed oil and hempseed oil supplementation on selected parameters of cardiovascular health in healthy volunteers J Am Coll Nutr. 27: 51-8.
  33. Nelson TL, Stevens JR, Hickey MS. (2007). Inflammatory markers are not altered by an eight week dietary alpha-linolenic acid intervention in healthy abdominally obese adult males and females Cytokine. 38: 101-6.
  34. Faintuch J, Horie LM, Barbeiro HV, et al. (2007). Systemic inflammation in morbidly obese subjects: response to oral supplementation with alpha-linolenic acid Obes Surg. 17: 341-7.
  35. Cassani RS, Fassini PG, Silvah JH, Lima CM, Marchini JS. (2015). Impact of weight loss diet associated with flaxseed on inflammatory markers in men with cardiovascular risk factors: a clinical study Nutr J. 14: 1-8.
  36. Demark-Wahnefried W, et al. (2008). Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery Cancer Epidemiol Biomarkers Prevent. 17: 3577-87.
  37. Burdge GC, Calder PC. (2005). Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults Reprod Nutr Dev. 45: 581-97.
  38. James MJ, Gibson RA, Cleland LG. (2000). Dietary polyunsaturated fatty acids and inflammatory mediator production Am J Clin Nutr. 71: 343s-8s.
  39. Childs CE, Kew S, Finnegan YE, et al. (2014). Increased dietary alpha-linolenic acid has sex-specific effects upon eicosapentaenoic acid status in humans: re-examination of data from a randomised, placebo-controlled, parallel study Nutr J. 13: 113..
  40. Marangoni F, Colombo C, De Angelis, et al. (2004). Cigarette smoke negatively and dose-dependently affects the biosynthetic pathway of the n-3 polyunsaturated fatty acid series in human mammary epithelial cells Lipids. 39: 633-7.
  41. Burdge GC, Calder PC. (2006). Dietary alpha-linolenic acid and health-related outcomes: a metabolic perspective Nutr Res Rev. 19: 26-52.
  42. Goyens PL, Spilker ME, Zock PL, Katan MB, Mensink RP. (2006). Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio Am J Clin Nutr. 84: 44-53.
  43. Ursoniu S, Sahebkar A, Andrica F, et al. (2016). Effects of flaxseed supplements on blood pressure: a systematic review and meta-analysis of controlled clinical trial Clin Nutr. 35: 615-25.
  44. Mukker JK, Singh RS, Muir AD, Krol ES, Alcorn J. (2015). Comparative pharmacokinetics of purified flaxseed and associated mammalian lignans in male Wistar rats Br J Nutr. 113: 749-57.
  45. Calder PC. (2011). Fatty acids and inflammation: the cutting edge between food and pharma Eur J Pharmacol. 668: S50-8.
  46. Sahebkar A, Serban MC, Gluba-Brzózka A, et al. (2016). Lipid-modifying effects of nutraceuticals: an evidence-based approach Nutrition. 32: 1179-92.
  47. Banach M, Patti AM, Giglio RV, et al, International Lipid. (2018). The role of nutraceuticals in statin intolerant patients J Am Coll Cardiol. 72: 96-118.
  48. Patti AM, Al-Rasadi K, Giglio RV, et al. (2018). Natural approaches in metabolic syndrome management Arch Med Sci. 14: 422-41.
  49. Cicero AFG, Colletti A, Bajraktari G, et al. (2017). Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel Arch Med Sci. 13: 965-1005.
  50. Soran H, Adam S, Mohammad JB, et al. (2018). Hypercholesterolaemia – practical information for non-specialists Arch Med Sci. 14: 1-21.
 

© 2023 Lipid and Blood Pressure Meta-Analysis Collaboration Group All Rights Reserved

Site map